Literature DB >> 4538330

Lupus-like syndrome, with persistent immunological abnormalities, related to procainamide therapy.

T P Anastassiades, J A Miliiken.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4538330      PMCID： PMC1940765     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Procainamide-induced lupus erythematosus.

Authors:  A T LADD
Journal:  N Engl J Med       Date:  1962-12-27       Impact factor: 91.245

2.  The treatment of myotonia: a controlled clinical trial.

Authors:  P LEYBURN; J N WALTON
Journal:  Brain       Date:  1959-03       Impact factor: 13.501

3.  Treatment of myotonia with procainamide.

Authors:  D S MACROBBIE; W J FRIEDLANDER
Journal:  AMA Arch Neurol Psychiatry       Date:  1957-11

4.  The use of procaine amide in cardiac arrhythmias.

Authors:  H J KAYDEN; J M STEELE; L C MARK; B B BRODIE
Journal:  Circulation       Date:  1951-07       Impact factor: 29.690

5.  Lupus-like syndrome induced by procainamide.

Authors:  A M Fakhro; R F Ritchie; B Lown
Journal:  Am J Cardiol       Date:  1967-09       Impact factor: 2.778

6.  Antinuclear antibody induced by procainamide. A prospective study.

Authors:  S E Blomgren; J J Condemi; M C Bignall; J H Vaughan
Journal:  N Engl J Med       Date:  1969-07-10       Impact factor: 91.245

7.  Natural antibodies to procaine amide.

Authors:  A S Russell; M Ziff
Journal:  Clin Exp Immunol       Date:  1968-11       Impact factor: 4.330

8.  Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism.

Authors:  R D Wochner; G Drews; W Strober; T A Waldmann
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

9.  Myotonia, procaine amide, and lupus-like syndrome.

Authors:  L D Prockop
Journal:  Arch Neurol       Date:  1966-03

10.  Procainamide induced lupus erythematosus syndrome.

Authors:  H S Sanford; A K Michaelson; M M Halpern
Journal:  Dis Chest       Date:  1967-02
View more
  2 in total

1.  A new sustained-release tablet formulation of procainamide.

Authors:  D Fremstad; S Dahl; S Jacobsen; P K Lunde; K J Nådland; A A Marthinsen; T Waaler; K H Landmark
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

2.  Myotonic dystrophy and multiple sclerosis.

Authors:  C F Terrence
Journal:  J Neurol       Date:  1976-10-04       Impact factor: 4.849
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.